These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19654288)

  • 1. Unwelcome complement.
    Markiewski MM; Lambris JD
    Cancer Res; 2009 Aug; 69(16):6367-70. PubMed ID: 19654288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement inhibition in cancer therapy.
    Pio R; Ajona D; Lambris JD
    Semin Immunol; 2013 Feb; 25(1):54-64. PubMed ID: 23706991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate immune mediators in cancer: between defense and resistance.
    Berraondo P; Minute L; Ajona D; Corrales L; Melero I; Pio R
    Immunol Rev; 2016 Nov; 274(1):290-306. PubMed ID: 27782320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement as a Biological Tool to Control Tumor Growth.
    Macor P; Capolla S; Tedesco F
    Front Immunol; 2018; 9():2203. PubMed ID: 30319647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer and complement.
    Ostrand-Rosenberg S
    Nat Biotechnol; 2008 Dec; 26(12):1348-9. PubMed ID: 19060872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid-derived suppressor cell role in tumor-related inflammation.
    Dolcetti L; Marigo I; Mantelli B; Peranzoni E; Zanovello P; Bronte V
    Cancer Lett; 2008 Aug; 267(2):216-25. PubMed ID: 18433992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate Immune Defense Mechanisms by Myeloid Cells That Hamper Cancer Immunotherapy.
    Lebegge E; Arnouk SM; Bardet PMR; Kiss M; Raes G; Van Ginderachter JA
    Front Immunol; 2020; 11():1395. PubMed ID: 32733461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer exploiting complement: a clue or an exception?
    Loveland BE; Cebon J
    Nat Immunol; 2008 Nov; 9(11):1205-6. PubMed ID: 18936777
    [No Abstract]   [Full Text] [Related]  

  • 9. Modulation of the antitumor immune response by complement.
    Markiewski MM; DeAngelis RA; Benencia F; Ricklin-Lichtsteiner SK; Koutoulaki A; Gerard C; Coukos G; Lambris JD
    Nat Immunol; 2008 Nov; 9(11):1225-35. PubMed ID: 18820683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sweet escape: sialic acids in tumor immune evasion.
    Büll C; den Brok MH; Adema GJ
    Biochim Biophys Acta; 2014 Aug; 1846(1):238-46. PubMed ID: 25026312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Membrane Bound Complement Regulatory Proteins in Tumor Development and Cancer Immunotherapy.
    Geller A; Yan J
    Front Immunol; 2019; 10():1074. PubMed ID: 31164885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting innate immune pathways in cancer immunotherapy: state of the art.
    Mastellos DC
    J BUON; 2009 Sep; 14 Suppl 1():S123-30. PubMed ID: 19785054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The complement system in cancer: Ambivalence between tumour destruction and promotion.
    Mamidi S; Höne S; Kirschfink M
    Immunobiology; 2017 Jan; 222(1):45-54. PubMed ID: 26686908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer cells release anaphylatoxin C5a from C5 by serine protease to enhance invasiveness.
    Nitta H; Murakami Y; Wada Y; Eto M; Baba H; Imamura T
    Oncol Rep; 2014 Oct; 32(4):1715-9. PubMed ID: 25050844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the complement system and the activation fragment C5a in the central nervous system.
    Woodruff TM; Ager RR; Tenner AJ; Noakes PG; Taylor SM
    Neuromolecular Med; 2010 Jun; 12(2):179-92. PubMed ID: 19763906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement System: An Immunotherapy Target in Colorectal Cancer.
    Talaat IM; Elemam NM; Saber-Ayad M
    Front Immunol; 2022; 13():810993. PubMed ID: 35173724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of complement in tumor growth.
    Pio R; Corrales L; Lambris JD
    Adv Exp Med Biol; 2014; 772():229-62. PubMed ID: 24272362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting complement in therapy.
    Kirschfink M
    Immunol Rev; 2001 Apr; 180():177-89. PubMed ID: 11414360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumor microenvironment and its role in promoting tumor growth.
    Whiteside TL
    Oncogene; 2008 Oct; 27(45):5904-12. PubMed ID: 18836471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial: The Role of Complement in Tumors.
    Rolfe BE; Pio R; Woodruff TM; Markiewski MM; Manthey HD
    Front Immunol; 2020; 11():139. PubMed ID: 32117286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.